MORGAN GILBERT: Open Payments
NPI 1043980477 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 13 payments from 9 companies in 2025. Trend: 2023 $258 · 2024 $185 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Novo Nordisk Inc | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: LOKELMA, VERQUVO, Wegovy, JARDIANCE, Kerendia, AMVUTTRA, LifeVest, ELIQUIS.
Industry payments across TX — which companies pay providers there.
